Robust Literature & ICSR Support to Enhance Safety Monitoring
In the landscape of global drug safety, simply collecting case reports isn’t enough — you need to contextualize them with scientific literature and regulatory experience. Our ICSR & Literature Support service provides a dual-pronged approach: high-quality case management coupled with literature-driven signal intelligence.
We maintain a dedicated team that continuously screens peer-reviewed journals, conference publications, regulatory databases, and real-world data sources for safety signals. When a potential risk emerges, our medical reviewers critically appraise the literature, cross-reference ICSRs, and draft risk summaries or signal reports. This integration of individual case insights and scientific evidence helps sponsors make well-informed risk-benefit decisions.
Additionally, our ICSR operations handle data entry, medical review, regulatory submission, and tracking of follow-up information. All case reports are maintained with precision, and Literature Support ensures that no relevant published evidence is missed. This combined strategy boosts signal detection accuracy, supports regulatory compliance, and elevates the quality of the pharmacovigilance system.
